Skip to main content
Year archive

OPKO Health Inc. — 2020 filings

All 214 regulatory filings released by OPKO Health Inc. (OPK) in 2020, sourced directly from the official regulator.

214 Filings
2020 Period
2020 filings (214)
Filing Released Lang
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP M.D. ET AL
Director's Dealing
2020-12-29 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP M.D. ET AL
Regulatory Filings
2020-12-29 English
Form 8-K-The Board of Directors of OPKO appointed Roger J. Medel, M.D. as a new director with immediate effect.
Board/Management Information
2020-12-21 English
Form 8-K-The Board of Directors of OPKO appointed Roger J. Medel, M.D. as a new director with immediate effect.
Board/Management Information
2020-12-21 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-12-21 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-12-21 English
FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-12-21 English
FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-12-21 English
OPKO Health Appoints Dr. Roger Medel to its Board of Directors
Board/Management Information
2020-12-21 English
OPKO Health Appoints Dr. Roger Medel to its Board of Directors
Board/Management Information
2020-12-21 English
Schedule 13DA Of The company in Cocrystal Pharma, Inc
Major Shareholding Notification
2020-11-21 English
Schedule 13DA Of The company in Cocrystal Pharma, Inc
Regulatory Filings
2020-11-21 English
OPKO Health to Participate in Three Upcoming Investment Conferences
Report Publication Announcement
2020-11-11 English
OPKO Health to Participate in Three Upcoming Investment Conferences
Report Publication Announcement
2020-11-11 English
FORM 4- STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- FROST PHILLIP
Director's Dealing
2020-11-10 English
FORM 4- STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- FROST PHILLIP
Regulatory Filings
2020-11-10 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-11-02 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Regulatory Filings
2020-11-02 English
Form 10-Q-result three months 2020
Interim / Quarterly Report 9M 2020
2020-10-31 English
Form 10-Q-result three months 2020
Report Publication Announcement
2020-10-31 English
Reports 2020 Third Quarter Business Highlights and Financial Results
Earnings Release Q3 2020
2020-10-31 English
Reports 2020 Third Quarter Business Highlights and Financial Results
Report Publication Announcement
2020-10-31 English
BioReference Laboratories Launches Multiplex COVID-19 and Influenza A/B Test
Regulatory Filings
2020-10-20 English
BioReference Laboratories Launches Multiplex COVID-19 and Influenza A/B Test
Report Publication Announcement
2020-10-20 English
OPKO Health to Report Third Quarter 2020 Financial Results and conference call on October 29, 2020
Earnings Release Q3 2020
2020-10-13 English
OPKO Health to Report Third Quarter 2020 Financial Results and conference call on October 29, 2020
Report Publication Announcement
2020-10-13 English
OPKO Launches COVID-19 Testing Program for New York City Schools
Regulatory Filings
2020-10-09 English
OPKO Launches COVID-19 Testing Program for New York City Schools
Regulatory Filings
2020-10-09 English
Announces Positive Phase 3 Top-line Results for Once-Weekly Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency
Regulatory Filings
2020-10-08 English
Announces Positive Phase 3 Top-line Results for Once-Weekly Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency
Regulatory Filings
2020-10-08 English
Presentation, September 2020
Investor Presentation
2020-09-15 English
Presentation, September 2020
Report Publication Announcement
2020-09-15 English
attended the H.C. Wainwright 22nd Annual Global Investment Virtual Conference and participated in one on one meetings with investors
Regulatory Filings
2020-09-15 English
attended the H.C. Wainwright 22nd Annual Global Investment Virtual Conference and participated in one on one meetings with investors
Report Publication Announcement
2020-09-15 English
Initiates Clinical Trial of RAYALDEE in COVID-19 Patients
Regulatory Filings
2020-09-15 English
Initiates Clinical Trial of RAYALDEE in COVID-19 Patients
Report Publication Announcement
2020-09-15 English
Participate in Two September Investment Conferences
Report Publication Announcement
2020-09-03 English
Participate in Two September Investment Conferences
Report Publication Announcement
2020-09-03 English
OPKO Health’s BioReference Laboratories Announces New York City Schools COVID-19 Testing Program
Regulatory Filings
2020-09-02 English
OPKO Health’s BioReference Laboratories Announces New York City Schools COVID-19 Testing Program
Report Publication Announcement
2020-09-02 English
OPKO Health’s BioReference Laboratories Launches Best-in-Class Next-Generation Sequencing (NGS) Assay
Regulatory Filings
2020-09-01 English
OPKO Health’s BioReference Laboratories Launches Best-in-Class Next-Generation Sequencing (NGS) Assay
Report Publication Announcement
2020-09-01 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-08-28 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-08-28 English
OPKO Health to Participate in BTIG Virtual Biotechnology Conference
Regulatory Filings
2020-08-05 English
OPKO Health to Participate in BTIG Virtual Biotechnology Conference
Regulatory Filings
2020-08-05 English
FORM 10-Q -For the quarterly period ended June 30, 2020.
Interim / Quarterly Report Q2 2020
2020-07-31 English
FORM 10-Q -For the quarterly period ended June 30, 2020.
Report Publication Announcement
2020-07-31 English
Form 8-K - OPKO Announces Second Quarter Operating and Financial Results
Earnings Release Q2 2020
2020-07-31 English
Form 8-K - OPKO Announces Second Quarter Operating and Financial Results
Earnings Release Q2 2020
2020-07-31 English
OPKO Health Reports 2020 Second Quarter Business Highlights and Financial Results
Earnings Release Q2 2020
2020-07-30 English
OPKO Health Reports 2020 Second Quarter Business Highlights and Financial Results
Report Publication Announcement
2020-07-30 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES BY Pfenniger, Jr. Richard C
Director's Dealing
2020-07-27 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES BY Pfenniger, Jr. Richard C
Director's Dealing
2020-07-27 English
OPKO Health to Report Second Quarter 2020 Financial Results on July 30, 2020
Earnings Release Q2 2020
2020-07-27 English
OPKO Health to Report Second Quarter 2020 Financial Results on July 30, 2020
Report Publication Announcement
2020-07-27 English
FORM 3- INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES-Cohen Jon R M.D
Major Shareholding Notification
2020-07-25 English
FORM 3- INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES-Cohen Jon R M.D
Director's Dealing
2020-07-25 English
FORM 3- INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES-Hernandez Rulfo F
Major Shareholding Notification
2020-07-25 English
FORM 3- INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES-Hernandez Rulfo F
Director's Dealing
2020-07-25 English
FORM 8-K,Appointment of Certain Officers
Board/Management Information
2020-07-25 English
FORM 8-K,Appointment of Certain Officers
Report Publication Announcement
2020-07-25 English
Executive Chairman of BioReference had reached an agreement in principle with the National Football League provide COVID-19 testing for the NFL
Regulatory Filings
2020-07-21 English
Executive Chairman of BioReference had reached an agreement in principle with the National Football League provide COVID-19 testing for the NFL
Regulatory Filings
2020-07-21 English
BioReference Laboratories Awarded Commercial Surge Capacity Testing for COVID-19 Emergency Response Contract by Centers for Disease Control
Regulatory Filings
2020-07-20 English
BioReference Laboratories Awarded Commercial Surge Capacity Testing for COVID-19 Emergency Response Contract by Centers for Disease Control
Report Publication Announcement
2020-07-20 English
OPKO Health’s BioReference Laboratories to Provide COVID-19 Testing for National Basketball Association Players and Employees
Regulatory Filings
2020-07-13 English
OPKO Health’s BioReference Laboratories to Provide COVID-19 Testing for National Basketball Association Players and Employees
Report Publication Announcement
2020-07-13 English
Major League Soccer Chooses OPKO Health's BioReference Laboratories to Provide COVID-19 Testing for Players and Employees
Regulatory Filings
2020-07-09 English
Major League Soccer Chooses OPKO Health's BioReference Laboratories to Provide COVID-19 Testing for Players and Employees
Report Publication Announcement
2020-07-09 English
OPKO Health’s BioReference Laboratories Reports Results of COVID-19 Testing for Almost One Quarter of a Million Nursing Home Employees
Earnings Release Q2 2020
2020-07-01 English
OPKO Health’s BioReference Laboratories Reports Results of COVID-19 Testing for Almost One Quarter of a Million Nursing Home Employees
Report Publication Announcement
2020-07-01 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Yu, M.D., PhD. Alice Lin-Tsing
Director's Dealing
2020-06-27 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Yu, M.D., PhD. Alice Lin-Tsing
Regulatory Filings
2020-06-27 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Pfenniger, Jr. Richard C
Director's Dealing
2020-06-27 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Pfenniger, Jr. Richard C
Report Publication Announcement
2020-06-27 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Paganelli John A
Director's Dealing
2020-06-27 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Paganelli John A
Regulatory Filings
2020-06-27 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-06-27 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Regulatory Filings
2020-06-27 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-06-27 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Report Publication Announcement
2020-06-27 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-06-27 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Regulatory Filings
2020-06-27 English
Form 8-K Annual Meeting Transcript
AGM Information
2020-06-27 English
Form 8-K Annual Meeting Transcript
AGM Information
2020-06-27 English
FORM 8K- Annual Meeting
AGM Information
2020-06-27 English
FORM 8K- Annual Meeting
AGM Information
2020-06-27 English
OPKO somatrogon Japan top-line result
Earnings Release FY 2019
2020-06-09 English
OPKO somatrogon Japan top-line result
Report Publication Announcement
2020-06-09 English
FORM 4- STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-06-08 English
FORM 4- STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Report Publication Announcement
2020-06-08 English
FORM 4 - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-06-08 English
FORM 4 - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Regulatory Filings
2020-06-08 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-06-08 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Report Publication Announcement
2020-06-08 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-06-08 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Report Publication Announcement
2020-06-08 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-06-06 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Report Publication Announcement
2020-06-06 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-06-03 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Report Publication Announcement
2020-06-03 English
FDA Authorizes OPKO Health Clinical Trial Evaluating RAYALDEE in COVID-19 Patients
Regulatory Filings
2020-06-01 English
FDA Authorizes OPKO Health Clinical Trial Evaluating RAYALDEE in COVID-19 Patients
Report Publication Announcement
2020-06-01 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-05-30 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Regulatory Filings
2020-05-30 English
OPKO Health to Present at the Jefferies Virtual Healthcare Conference
Report Publication Announcement
2020-05-27 English
OPKO Health to Present at the Jefferies Virtual Healthcare Conference
Report Publication Announcement
2020-05-27 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-05-27 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Regulatory Filings
2020-05-27 English
OPKO Health, Inc. and Pfizer entered into an amendment to Development, Commercialization License Agreement, for OPKO's long-acting human growth hormone product (hGH-CTP)
Regulatory Filings
2020-05-16 English
OPKO Health, Inc. and Pfizer entered into an amendment to Development, Commercialization License Agreement, for OPKO's long-acting human growth hormone product (hGH-CTP)
Report Publication Announcement
2020-05-16 English
interested party transaction
Director's Dealing
2020-05-09 English
interested party transaction
Report Publication Announcement
2020-05-09 English
OPKO Health Reports 2020 First Quarter Business Highlights and Financial Results
Earnings Release Q1 2020
2020-05-07 English
OPKO Health Reports 2020 First Quarter Business Highlights and Financial Results
Report Publication Announcement Q1 2020
2020-05-07 English
OPKO Health Reports 2020 First Quarter Business Highlights and Financial Results
Earnings Release Q1 2020
2020-05-07 English
OPKO Health Reports 2020 First Quarter Business Highlights and Financial Results
Earnings Release Q1 2020
2020-05-07 English
OPKO Health to Report First Quarter 2020 Financial Results on May 6, 2020
Report Publication Announcement
2020-05-02 English
OPKO Health to Report First Quarter 2020 Financial Results on May 6, 2020
Report Publication Announcement
2020-05-02 English
Notice regarding the availability of proxy materials for Annual Meeting of Stockholders to be held on June 25, 2020
Proxy Solicitation & Information Statement
2020-04-29 English
Notice regarding the availability of proxy materials for Annual Meeting of Stockholders to be held on June 25, 2020
Proxy Solicitation & Information Statement
2020-04-29 English
NOTICE OF 2020 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD JUNE 25, 2020
Proxy Solicitation & Information Statement
2020-04-29 English
NOTICE OF 2020 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD JUNE 25, 2020
AGM Information
2020-04-29 English
Somatrogon Phase 3 Pediatric Trial Results will be presented on June 8 at ENDO Online 2020
Report Publication Announcement
2020-04-22 English
Somatrogon Phase 3 Pediatric Trial Results will be presented on June 8 at ENDO Online 2020
Report Publication Announcement
2020-04-22 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-04-20 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-04-20 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-04-18 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Report Publication Announcement
2020-04-18 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-04-16 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-04-16 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-04-09 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Regulatory Filings
2020-04-09 English
CHANGES IN BENEFICIAL OWNERSHIP-FORM 4-FROST PHILLIP M.D. ET AL
Director's Dealing
2020-04-06 English
CHANGES IN BENEFICIAL OWNERSHIP-FORM 4-FROST PHILLIP M.D. ET AL
Director's Dealing
2020-04-06 English
FORM 4 - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-04-04 English
FORM 4 - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Report Publication Announcement
2020-04-04 English
FORM 4- STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-04-04 English
FORM 4- STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Report Publication Announcement
2020-04-04 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-03-31 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-03-31 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Major Shareholding Notification
2020-03-31 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-03-31 English
FORM 4 - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-03-30 English
FORM 4 - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-03-30 English
FORM 4 - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-03-28 English
FORM 4 - STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Report Publication Announcement
2020-03-28 English
Reports Interim Results for Two Ongoing RAYALDEE Studies
Earnings Release Q1 2020
2020-03-25 English
Reports Interim Results for Two Ongoing RAYALDEE Studies
Regulatory Filings
2020-03-25 English
OPKO Health’s BioReference Laboratories and City of Miami Provide Testing for Coronavirus Disease 2019 (COVID-19)
Regulatory Filings
2020-03-24 English
OPKO Health’s BioReference Laboratories and City of Miami Provide Testing for Coronavirus Disease 2019 (COVID-19)
Report Publication Announcement
2020-03-24 English
OPKO Health’s BioReference Laboratories and City of Detroit Provide Testing for Coronavirus Disease 2019 (COVID-19)
Regulatory Filings
2020-03-23 English
OPKO Health’s BioReference Laboratories and City of Detroit Provide Testing for Coronavirus Disease 2019 (COVID-19)
Report Publication Announcement
2020-03-23 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Major Shareholding Notification
2020-03-21 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Regulatory Filings
2020-03-21 English
SCHEDULE 13D/A-Hsu Gamma Investment, L.P.
Major Shareholding Notification
2020-03-21 English
SCHEDULE 13D/A-Hsu Gamma Investment, L.P.
Regulatory Filings
2020-03-21 English
OPKO Health’s BioReference Laboratories and NYC Health + Hospitals Enter into Laboratory Collaboration to Provide Testing for Coronavirus Disease 2019 (COVID-19)
Regulatory Filings
2020-03-17 English
OPKO Health’s BioReference Laboratories and NYC Health + Hospitals Enter into Laboratory Collaboration to Provide Testing for Coronavirus Disease 2019 (COVID-19)
Report Publication Announcement
2020-03-17 English
OPKO’s BioReference Laboratories Offers Testing for Coronavirus Disease 2019
Regulatory Filings
2020-03-14 English
OPKO’s BioReference Laboratories Offers Testing for Coronavirus Disease 2019
Regulatory Filings
2020-03-14 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-03-13 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Report Publication Announcement
2020-03-13 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-03-11 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Regulatory Filings
2020-03-11 English
SCHEDULE 13D/A- Cocrystal Pharma, Inc.
Major Shareholding Notification
2020-03-10 English
SCHEDULE 13D/A- Cocrystal Pharma, Inc.
Regulatory Filings
2020-03-10 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-03-08 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Report Publication Announcement
2020-03-08 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-03-04 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-03-04 English
Annual Report on Form 10-K for the year ended December 31, 2019
Annual Report FY 2019
2020-03-03 English
Annual Report on Form 10-K for the year ended December 31, 2019
Report Publication Announcement FY 2019
2020-03-03 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-03-02 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Report Publication Announcement
2020-03-02 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-02-29 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Report Publication Announcement
2020-02-29 English
Form 8-K: Reports 2019 Fourth Quarter Business Highlights and Financial Results
Regulatory Filings
2020-02-26 English
Form 8-K: Reports 2019 Fourth Quarter Business Highlights and Financial Results
Report Publication Announcement
2020-02-26 English
Reports 2019 Fourth Quarter Business Highlights and Financial Results
Earnings Release Q4 2019
2020-02-26 English
Reports 2019 Fourth Quarter Business Highlights and Financial Results
Earnings Release Q4 2019
2020-02-26 English
Report Fourth Quarter 2019 Financial Results on February 26, 2020
Report Publication Announcement
2020-02-22 English
Report Fourth Quarter 2019 Financial Results on February 26, 2020
Report Publication Announcement
2020-02-22 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Major Shareholding Notification
2020-02-18 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Report Publication Announcement
2020-02-18 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP M.D. ET AL
Director's Dealing
2020-02-15 English
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FROST PHILLIP M.D. ET AL
Regulatory Filings
2020-02-15 English
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Director's Dealing
2020-02-12 English
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Report Publication Announcement
2020-02-12 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FORM 4-FROST PHILLIP
Director's Dealing
2020-02-08 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FORM 4-FROST PHILLIP
Report Publication Announcement
2020-02-08 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FORM 4-FROST PHILLIP
Director's Dealing
2020-02-03 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FORM 4-FROST PHILLIP
Report Publication Announcement
2020-02-03 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FORM 4-FROST PHILLIP
Major Shareholding Notification
2020-02-01 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FORM 4-FROST PHILLIP
Regulatory Filings
2020-02-01 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FORM 4-FROST PHILLIP
Director's Dealing
2020-01-27 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-FORM 4-FROST PHILLIP
Regulatory Filings
2020-01-27 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-01-25 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Regulatory Filings
2020-01-25 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-01-21 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Report Publication Announcement
2020-01-21 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-01-14 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Report Publication Announcement
2020-01-14 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-01-13 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Report Publication Announcement
2020-01-13 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-01-09 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-01-09 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-01-08 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Report Publication Announcement
2020-01-08 English
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-01-08 English
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2020-01-08 English
OPKO Health appointed Anthony Japour, M.D. as a new director effective as of January 6, 2020.
Board/Management Information
2020-01-08 English
OPKO Health appointed Anthony Japour, M.D. as a new director effective as of January 6, 2020.
Board/Management Information
2020-01-08 English